Last $9.36 USD
Change Today -0.85 / -8.37%
Volume 38.3K
ROKA On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 5:20 PM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul G. Thomas

Founder, Chief Executive Officer, President and Director, Roka Bioscience, Inc.
AgeTotal Calculated CompensationThis person is connected to 32 board members in 4 different organizations across 9 different industries.

See Board Relationships
58$1,702,300
As of Fiscal Year 2013

Background*

Mr. Paul G. Thomas founded Roka Bioscience, Inc., in 2009 and has been its Chief Executive Officer and President since September 2009. Mr. Thomas has an extensive background leading biotechnology companies, particularly through a variety of successful financial transactions. Mr. Thomas served as the Executive Chairman of LifeCell Corporation since June 1999 and Chief Executive Officer and President from October 1998 to August 2008. Prior to joining LifeCell, he held ...

Read Full Background

Corporate Headquarters*

20 Independence Boulevard
Warren, New Jersey 07059

United States

Phone: 908-605-4700
Fax: --

Board Members Memberships*

Former Director
Chairman
1998-2008
Former Chief Executive Officer and President
2005-N/A
Former Independent Outside Director
2007-2011
Former Chairman of Compensation Committee and Director
2009-Present
Founder, Chief Executive Officer, President and Director
2011-Present
Director and Chairman of Governance & Nominating Committee
2011-Present
Director and Member of Audit Committee

Education*

MBA
Columbia Business School
Master's Degree
University of Georgia Graduate School of Arts and Science
BS
Saint Michael's College

Other Affiliations*

Annual Compensation*

Salary$457,675
Total Annual Compensation$457,675

Stock Options*

Restricted Stock Awards$1,224,000
All Other Compensation$20,625

Total Compensation*

Total Annual Cash Compensation$478,300
Total Short Term Compensation$457,675
Other Long Term Compensation$1,244,625
Total Calculated Compensation$1,702,300
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROKA:US $9.36 USD -0.85

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Norman D. Schwartz Chairman, Chief Executive Officer and President
Bio-Rad Laboratories, Inc.
$810.0K
James L. Herbert Chairman, Chief Executive Officer, Interim President and Interim Chief Operating Officer
Neogen Corp.
$532.0K
Alexandre Mérieux Chief Executive Officer, Director and Member of Strategy Committee
bioMérieux SA
€544.9K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROKA BIOSCIENCE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.